Impact of optimal anti-proteinuric therapy on the prevention of diabetic kidney disease progression

Impact of optimal anti-proteinuric therapy on the prevention of diabetic kidney disease progression

Abstract Diabetic kidney disease (DKD) is the leading global cause of end-stage renal disease (ESRD), with its prevalence rising, particularly in resource-limited settings. Antiproteinuric medications are central to DKD management, but their optimal utilization is expected to be low in such settings...

Full description

Saved in:
Bibliographic Details
Main Authors: Saed Ahmed Ismail, Molla Asnake Kebede, Getachew Wondafrash, Rediet Ambachew, Rukia Abukar Abdi, Elias Tabit Ahmed, Missgana Worku Belete, Misikr Alemu Eshetu, Subah Abderehim Yesuf
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Diabetic kidney disease
Antiproteinuric medications
Utilization
Optimization
Associated factors
Online Access:https://doi.org/10.1038/s41598-025-09952-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-09952-6

Similar Items